Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.15 USD | +0.23% | +0.43% | -7.50% |
Feb. 28 | Inhibrx Shares Fall After Q4 Net Loss Widens | MT |
Feb. 28 | Earnings Flash (INBX) INHIBRX Reports Q4 Revenue $1.6M | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 2M | Capitalization | 1.67B |
---|---|---|---|---|---|
Net income 2024 * | -199M | Net income 2025 * | -252M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 835 x |
P/E ratio 2024 * |
-8.91
x | P/E ratio 2025 * |
-8.78
x | Employees | 169 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.24% |
1 day | +0.23% | ||
1 week | +0.43% | ||
Current month | -4.04% | ||
1 month | -11.15% | ||
3 months | +2.03% | ||
6 months | +76.46% | ||
Current year | -7.50% |
Managers | Title | Age | Since |
---|---|---|---|
Brendan Eckelman
FOU | Founder | 45 | 10-03-31 |
Mark Lappe
CEO | Chief Executive Officer | 57 | 10-03-31 |
Kelly Deck
DFI | Director of Finance/CFO | 44 | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jon Kayyem
BRD | Director/Board Member | 60 | 18-03-31 |
Mark Lappe
CEO | Chief Executive Officer | 57 | 10-03-31 |
Kimberly Manhard
BRD | Director/Board Member | 64 | 20-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 12 M€ | -.--% | - | |
0.09% | 2 M€ | -.--% | ||
0.07% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 35.15 | +0.23% | 346,325 |
24-03-26 | 35.07 | +0.37% | 310,268 |
24-03-25 | 34.94 | +0.14% | 349,015 |
24-03-22 | 34.89 | -0.23% | 323,990 |
24-03-21 | 34.97 | -0.09% | 520,906 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.50% | 1.67B | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.57% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |